Retrospective Cohort Study of Low-Flow Extracorporeal Carbon Dioxide Removal (ECCO2R) System: Evaluating ECCO2R's Efficacy and Safety in Participants With Respiratory Failure

Recruiting now

Conditions studied: Respiratory Failure, ICU, Asthma (Diagnosis), ARDS

In brief

This is an observational study performed by retrospective review of data routinely collected for patients receiving low-flow extracorporeal carbon dioxide removal (ECCO2R) therapy in intensive care units (ICUs). Our aim is to firstly, describe the local practice in terms of patient selection and technical details of clinical management related to the use of low-flow ECCO2R system, and secondly, the clinical results in terms of patient outcomes and adverse events. These findings may allow clinicians to improve the quality and safety of ECCO2R therapy provision in the ICU.

Key facts

Study ID

NCT07161271

Run by

Hong Kong University

People needed

59

Starts

2024-11-01

Expected to finish

2027-06-30

Last updated by the study team

2025-12-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients supported with ECCO2R in one of the designated study sites
• Admitted to the ICU between 1 Jan 2022 and 30 June 2024

You may not qualify if…

• Patients younger than 18 years old

Where it is running

• Queen Mary Hospital (QMH) — Hong Kong, Hong Kong (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.